Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $147.8 million.

  • Alignment Healthcare's Net Cash Flow rose 896865.03% to $147.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $277.5 million, marking a year-over-year increase of 64736.26%. This contributed to the annual value of $230.0 million for FY2024, which is 21145.85% up from last year.
  • According to the latest figures from Q3 2025, Alignment Healthcare's Net Cash Flow is $147.8 million, which was up 896865.03% from $24.1 million recorded in Q2 2025.
  • Alignment Healthcare's 5-year Net Cash Flow high stood at $321.1 million for Q1 2021, and its period low was -$188.4 million during Q4 2023.
  • Moreover, its 5-year median value for Net Cash Flow was $5.9 million (2021), whereas its average is $21.7 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 47238.27% in 2021, then skyrocketed by 896865.03% in 2025.
  • Alignment Healthcare's Net Cash Flow (Quarter) stood at -$33.1 million in 2021, then plummeted by 377.25% to -$157.9 million in 2022, then decreased by 19.34% to -$188.4 million in 2023, then surged by 148.95% to $92.2 million in 2024, then soared by 60.25% to $147.8 million in 2025.
  • Its Net Cash Flow was $147.8 million in Q3 2025, compared to $24.1 million in Q2 2025 and $13.3 million in Q1 2025.